Stem Cell Stocks 5/17/09: The Week That Was

If you remember back to when the market was in its tailspin, one of the only plays that seemed to work were the stem cell stocks. With the overall market currently in a bit of a slide, it was interesting to see if the sector would again be a strong performer. However, nothing much has changed. The only upward movement has come from those individual stocks with news or out of the blue trading momentum.

Top Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Up 98% for the week; This stock acted very unusual last week. At one point the stock nearly tripled. Shares spiked on 8 times the average volume on four consecutive trading days. Friday it finally pulled back. All this movement occurred with no news. It looks like a huge short opportunity if you're into that.

Worst Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Down -24%; Stock has very low volume. Swings of this sort are not uncommon

Stem Cell Stocks Current Price and % Up or Down 5/11/09 - 5/15/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Up 5%
Aastrom Biosciences (ASTM) = Cur Price: $0.37; Down -6%
BioTime, Inc. (BTIM) = Cur Price: $2.60; Up 37%
Celgene Corp (CELG) = Cur Price: $39.79; Down -4%
Cytori Therapeutics (CYTX) = Cur Price: $2.80; Up 12%
Geron Corp (GERN) = Cur Price: $6.26; Up 1%
ThermoGenesis (KOOL) = Cur Price: $0.57; Up 6%
Osiris Therapeutics (OSIR) = Cur Price: $12.35; Down -7%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.14; Up 43%
Athersys Inc. (ATHX) = Cur Price: $0.82; Unchanged
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Up 14%
Bioheart Inc. (BHRT) = Cur Price: $0.65; Down -24%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0055; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -15%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.87; Up 98%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0105; Up 4%
Pluristem Therapeutics (PSTI) = Cur Price: $1.44; Up 9%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Down -4%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.049; Up 26%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

No comments:

Post a Comment